today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization (CRO) powered by healthcare intelligence, will immediately begin utilizing Medidata Clinical Data ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its ...

We recently published a list of 10 Best Beaten Down Stocks to Buy According to Analysts. In this article, we are going to ...

today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization (CRO) powered by healthcare intelligence, will immediately begin utilizing Medidata Clinical Data Studio on ...

Of the company’s many research specialties, this year’s sessions focused on optimizing decision-making, measuring impact and proving ROI, and ensuring the integrity of assessments in an increasingly ...

As a result, the organization can enhance ... www.3ds.com. About ICON plc ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we ...

Levi & Korsinsky files lawsuit against ICON plc over alleged investor misrepresentation. Learn key dates and how to get ...

The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a research note published on Friday, MarketBeat reports. The firm currently ...

European clinicians and scientists are to receive £5.5m in funding to form a world-leading research team tasked with making ...

Pathogen causes severe disease and poses significant challenges to global public health, with an urgent need for continuous ...

An executive order targeting the Smithsonian Institution is prompting questions over the organization’s past and who runs and ...